IoNIR Ridaforolimus-Eluting Coronary Stent System

DEVICE2 trials

Sponsors

Medinol Ltd.

Conditions

Cardiovascular DiseasesCoronary Artery DiseaseCoronary DiseaseCoronary StenosisNon-ST Elevated Myocardial Infarction

Unknown Phase

IonMAN Trial- First in Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System

Active, not recruitingNCT05364697

Medinol Ltd.Cardiovascular Diseases, Coronary Disease, Coronary Stenosis +1

Start: 2022-08-30End: 2029-12-31Target: 60Updated: 2024-11-21

IonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System

SuspendedNCT06071702

Medinol Ltd.Coronary Artery Disease, Coronary Stenosis

Start: 2025-08-07End: 2026-08-10Target: 30Updated: 2025-09-22